Abstract
Erlotinib 10-mg/mL Oral Suspension
Author(s): Allen Loyd V Jr
Issue: Nov/Dec 2016 - Volume 20, Number 6
Page(s): 508
Download in electronic PDF format for $75
Abstract
A formulation for preparing Erlotinib 10-mg/mL Oral Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.
Related Keywords
- formulation
- erlotinib
- hazardous medication
- cancer
- antineoplastic agent
- EGFR inhibitor
Related Categories
- CANCER AND AIDS
- FORMULATIONS
- HAZARDOUS DRUGS